Skip to main content

Cold, Cough and Sore Throat Remedies Market, 2016-2026 by Segmentation: Based on Product, Application and Region

Press Release   •   Jan 31, 2017 00:02 EST

Cold, Cough and Sore Throat Remedies Market Growth

Common cold, cough and sore throat are minor disorders of respiratory system, usually arises due to infection in respiratory tract and autoimmune response. The number of patients suffering from cold, cough and sore throat usually increases during monsoon and winter season, owing to fluctuations in the environmental conditions. Children and women under 35 years are more prone to suffer from cold, cough and sore. Underdeveloped immune system increases the risk of exposure to cold related infection viruses in children mostly. It is expected that children are three times more susceptible to cold and cough than an average adult.

Cold, Cough and Sore Throat Remedies Market: Drivers & Restraints

Global Cold, Cough and Sore Throat Remedies market is projected to grow rapidly due to increasing incidences of cold, cough infections, economic price and wide availability of products and demand for rapid and long lasting effective products by the patients. Rising demand for such remedial products is one of the major factor influencing the market growth. Other major drivers includes, and a growing trend to self-diagnose and self-treat minor ailments and growth in the child, senior and female populations. For instance, considering the irritation caused by common cold, Novartis AG launched its formulation ‘Otrivin Nasal Drops’ that act against cold for around 12 hours, followed by a number of similar formulations. Owing to large number of available and upcoming products, the market is expected to grow rapidly. However, number of side effects, threat of resistance and large manufacturing cost and distribution are some of the key restraints that might hamper the growth of the market.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1292

Cold, Cough and Sore Throat Remedies Market: Segmentation

Global cold, cough and sore throat remedies market is classified on the basis of class of drugs, route of administration and geography.

Based on class of drugs, the global cold, cough and sore throat remedies market is segmented into the following:

  • Antihistamines
  • Pain relievers
  • Expectorants
  • Bronchodilators
  • Decongestants
  • Antibiotics
  • Others

Based on route of administration, the global cold, cough and sore throat remedies market is segmented into the following:

  • Parenteral
  • Tablets
  • Lozenges
  • Oral Syrups
  • Nasal Drops
  • Others

Based on distribution channels, the global cold, cough and sore throat remedies market is segmented into the following:

  • Hospital Pharmacies
  • Retailer Pharmacies
  • Compounding Pharmacies

Cold, Cough and Sore Throat Remedies Market: Overview

Europe and North America are the important markets for Cold, Cough and Sore Throat Remedies. In Europe, mainly Germany, France, Netherlands, Spain and the U.K. are estimated to account for a major share of the Western Europe Cold, Cough and Sore Throat Remedies market over the forecast period. The developing countries such as India and China are growing with a higher CAGR compared to other countries of the world. By route of administration, oral syrups and nasal drops segments held half the share in the global cold, cough and sore throat remedies and the trend is forecast to continue through 2025. Based on class of drugs, antihistamines, bronchodilators and antibiotics are expected to register a substantial CAGR through the forecast period.

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1292

Cold, Cough and Sore Throat Remedies Market: Region-wise Outlook

Depending on geographic regions, the global cold, cough and sore throat remedies market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. Approximately 1 billion cases of the common cold occurs in U.S. annually. In U.S on average 200,000 Americans are hospitalized annually due to influenza, and flu-related deaths in the United States have been estimated to range from 3,000 to 49,000 over the past 30 years. North America is the largest revenue generating segment in global cold, cough and sore throat remedies market. The increasing prevalence of viral infections and rapid economic developments benefiting healthcare sectors in Asian countries is projected to drive the growth of cold, cough and sore throat market in Asia.

Cold, Cough and Sore Throat Remedies Market: Key Players

Some of the key players identified in the global contraceptives market are Bayer HealthCare AG, GlaxoSmithKline plc., Novartis AG, AstraZeneca plc., Procter & Gamble, Sun Pharmaceuticals Ltd. and Abbott Laboratories.

Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

Contact

3rd Floor,
207 Regent Street,
London - W1B 3HH
United Kingdom
T: + 44 (0) 20 7692 8790
D: +44 (0) 20 3287 4268
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

Comments (0)

Add comment

Comment